Journal of Heart and Lung Transplantation

Papers
(The H4-Index of Journal of Heart and Lung Transplantation is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation552
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial 269
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients176
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant121
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing105
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation103
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass103
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients85
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy85
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil79
Early Onset Malignancy in the First-Year After Heart Transplantation75
WITHDRAWN68
Older Donor Hearts for Heart Transplantation68
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension67
Comparative Analysis of Fontan Transplant Outcomes65
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report64
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes63
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD60
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience59
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation59
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients58
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade57
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients54
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status53
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome53
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD51
Utility of Breath Volatomic Analysis in Lung Transplant Recipients51
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models49
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis48
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation48
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion47
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience47
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES43
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY42
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation42
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation41
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial41
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients41
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis40
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation39
0.12656402587891